Healthy Lifestyle and Metabolic Dysfunction-Associated Steatotic Liver Disease: A Study of the Efficacy of Fatty Liver Regression
Open Access
- 26 December 2024
- journal article
- Published by Wolters Kluwer Health in Clinical and Translational Gastroenterology
- Vol. 16 (2) , e00806
Abstract
INTRODUCTION: Obesity is the primary cause of metabolic dysfunction-associated steatotic liver disease (MASLD). Healthy lifestyle management has potential value in the treatment of MASLD. METHODS: A total of 150 patients with MASLD diagnosed at the Health Management Center of our hospital were enrolled and randomly divided into a traditional treatment (control group, n = 75) and a healthy lifestyle group (observation group, n = 75). All patients underwent a 3-month intervention. Data on general information, body composition, glucose metabolism, lipid metabolism, and inflammatory factors were analyzed. RESULTS: The difference in the change in fatty liver grade was statistically significant (P < 0.05). There were statistically significant differences in treatment efficiency for physical conditions (P < 0.05), including body fat mass, body mass index, body weight, waist circumference, and waist-to-hip ratio. In addition, there were statistically significant differences in treatment efficiency for scales such as the Diet Rating Scale, Emotional Stress Scale, and Global Physical Activity Questionnaire (P < 0.05). Differences in treatment efficiency for body fat parameters, including percentage of body fat, visceral fat area, aspartate aminotransferase, and diastolic blood pressure, were also statistically significant (P < 0.05). After treatment, statistically significant differences were observed in interferon-γ, insulin, low-density lipoprotein cholesterol, triglycerides, and tumor necrosis factor-α (P < 0.05). DISCUSSION: Our study indicates that a healthy lifestyle can effectively promote the reduction of fatty liver grade in patients with MASLD, demonstrating positive effects in improving lipid metabolism and inflammatory responses in these patients.Keywords
This publication has 45 references indexed in Scilit:
- Natural history and progression of metabolic dysfunction-associated steatotic liver diseaseThe Lancet Gastroenterology & Hepatology, 2024
- Epidemiology and diagnosis of metabolic dysfunction-associated fatty liver diseaseHepatology International, 2024
- Dietary pattern modifies the risk of MASLD through metabolomic signatureJHEP Reports, 2024
- EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)Journal of Hepatology, 2024
- Current status and future trends of the global burden of MASLDTrends in Endocrinology & Metabolism, 2024
- The Positive Eating Scale: Associations with eating behavior, food choice, and body mass indexEating Behaviors, 2023
- Healthy Lifestyle Score Including Sleep Duration and Cardiovascular Disease RiskAmerican Journal of Preventive Medicine, 2022
- Bariatric Surgery in NAFLDDigestive Diseases and Sciences, 2022
- Association of Psychological Resilience With Healthy Lifestyle and Body Weight in Young AdulthoodJournal of Adolescent Health, 2021
- Effect of daily calcitriol supplementation with and without calcium on disease regression in non-alcoholic fatty liver patients following an energy-restricted diet: Randomized, controlled, double-blind trialClinical Nutrition, 2017